Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TRVI

Trevi Therapeutics, Inc.

CIK 0001563880 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$18.40
↓ 0.19 (-1.02%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$2.61B
P/E Ratio
-57.28
EPS
-0.32
Dividend Yield
Not covered
52W Position
88%
Beta
1.13

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
15.18
P/S
Not covered
EV/Revenue
Not covered
ROE
-26.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 88%
$5.93$20.15

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$42.76M
Total Assets
$193.44M
Free Cash Flow
-$42.10M

Recent news